Theres no evidence that they have any sort of substantially lingering effect once you stop taking them, said Patrick ONeil, Ph.D., director of the MUSC Weight Management Center and a professor in the Department of Psychiatry and Behavioral Sciences
But federal regulators are warning consumers that compounded GLP-1s are not FDA-approved and may carry risks, including dosing errors
Compounded and research-grade vials come in many sizes 5 mg, 10 mg, 15 mg, 24 mg, 50 mg so vial-by-vial math matters more than a generic chart
The term metabolite is usually used to describe small molecules, while broader application is often practiced
Safety & Side Effects Like other peptide therapies, Retatrutide may cause mild to moderate side effects
The FDA has raised concerns about the increased risk of dosing errors, improper storage and fraudulently labeled GLP-1s from compounding pharmacies